Oncotarget · 2017 · 210 citations · 25 references
Life SciencesBiochemistryOncologyCellular MetabolismMetabolismMolecular OncologyCancer MetabolismCellular Energy MetabolismEnergy MetabolismMetabolic ReprogrammingMetabolic Reprogramming In CancerRenal Cell CarcinomaAerobic GlycolysisGlycolysisLactate ProductionMetabolic Alterations In CancerMetabolic Pathway InhibitionTumor Cell MetabolismTumor MetabolismWarburg Effect
// Cristina Bianchi 1 , Chiara Meregalli 1 , Silvia Bombelli 1 , Vitalba Di Stefano 1 , Francesco Salerno 1 , Barbara Torsello 1 , Sofia De Marco 1 , Giorgio Bovo 2, 8 , Ingrid Cifola 3 , Eleonora Mangano 3 , Cristina Battaglia 4 , Guido Strada 5 , Giuseppe Lucarelli 6 , Robert H. Weiss 7 and Roberto A. Perego 1 1 School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy 2 Pathology Unit, ASST Monza, San Gerardo Hospital, Monza, Italy 3 Institute for Biomedical Technologies, National Research Council, Segrate, Italy 4 Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Italy 5 Urology Unit, ASST North Milan, Bassini Hospital, Cinisello Balsamo, Italy 6 Department of Emergency and Organ Transplantation-Urology, University of Bari, Bari, Italy 7 Division of Nephrology, Department of Internal Medicine, School of Medicine, and Cancer Center, University of California, Davis, CA, USA 8 Current address: Pathology Unit, ASST North Milan, Vimercate Hospital, Vimercate, Italy Correspondence to: Roberto A. Perego, email: roberto.perego@unimib.it Keywords: renal cell carcinoma; primary cell cultures; glucose and lipid metabolism reprogramming; Fuhrman grade Received: July 19, 2017 Accepted: November 14, 2017 Published: December 08, 2017 ABSTRACT Clear cell renal cell carcinoma (ccRCC) has a poor prognosis despite novel biological targeted therapies. Tumor aggressiveness and poor survival may correlate with tumor grade at diagnosis and with complex metabolic alterations, also involving glucose and lipid metabolism. However, currently no grade-specific metabolic therapy addresses these alterations. Here we used primary cell cultures from ccRCC of low- and high-grade to investigate the effect on energy state and reduced pyridine nucleotide level, and on viability and proliferation, of specific inhibition of glycolysis with 2-deoxy-D-glucose (2DG), or fatty acid oxidation with Etomoxir. Our primary cultures retained the tissue grade-dependent modulation of lipid and glycogen storage and aerobic glycolysis (Warburg effect). 2DG affected lactate production, energy state and reduced pyridine nucleotide level in high-grade ccRCC cultures, but the energy state only in low-grade. Rather, Etomoxir affected energy state in high-grade and reduced pyridine nucleotide level in low-grade cultures. Energy state and reduced pyridine nucleotide level were evaluated by ATP and reduced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) dye quantification, respectively. 2DG treatment impaired cell proliferation and viability of low-grade ccRCC and normal cortex cultures, whereas Etomoxir showed a cytostatic and cytotoxic effect only in high-grade ccRCC cultures. Our data indicate that in ccRCC the Warburg effect is a grade-dependent feature, and fatty acid oxidation can be activated for different grade-dependent metabolic needs. A possible grade-dependent metabolic therapeutic approach in ccRCC is also highlighted.
25
Comprehensive molecular characterization of clear cell renal cell carcinoma
Michael V. Berridge, An S. Tan · Archives of Biochemistry and Biophysics · 1993 · 1.4K citations
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi, Ed Reznik, Chung‐Han Lee et al. · Cancer Cell · 2016 · 854 citations · Full text
Medicine, Cell Biology, Oncology +14